| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
JCRB0070 |
MIA PaCa-2 |
human |
pancreas |
pancreatic cancer |
|
| 2 | general cells |
JCRB0123 |
KO52 |
human |
bone marrow |
leukemia, acute myeloblastic |
|
| 3 | general cells |
JCRB0152.3 |
M.P3 |
rat |
liver |
M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium. |
|
| 4 | general cells |
JCRB0207 |
CaR-1 |
human |
rectum |
adenocarcinoma |
|
| 5 | general cells |
JCRB0230 |
SCC-131 |
rat |
|
Rat squamous cell carcinoma cell line. |
|
| 6 | general cells |
JCRB0248 |
ARLJ301-3 |
rat |
liver |
liver epithelial cell, (F344/DuCrj rat) |
|
| 7 | general cells |
JCRB0418 |
dRLN-4 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
| 8 | general cells |
JCRB1098 |
hs-171-1 |
hamster, Chinese |
lung |
Temperature sensitive mutant of Chinese hamster lung cell line. |
|
| 9 | general cells |
JCRB1139 |
KUM9 |
mouse |
Bone marrow |
Osteoblastic cell line of mouse C3H. |
|
| 10 | general cells |
JCRB1358.06 |
SRBC-F23-20-22 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 11 | general cells |
JCRB1398 |
Kasumi-5 |
human |
blood |
T cell leukemia |
|
| 12 | general cells |
JCRB1427 |
KMP2 |
human |
liver metastasis |
Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis. |
|
| 13 | general cells |
JCRB1470 |
SUm/c |
human |
xenograft |
SUm/c was established from floating in the lymph of the thoracic duct of patients with esophageal squamous cell carcinoma. |
|
| 14 | general cells |
JCRB1472 |
KYSE2300 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 15 | genetically-modified cells |
JCRB1489 |
POLZ D2781N |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low activity, TK+/-) |
|
| 16 | genetically-modified cells |
JCRB1572 |
HAdpc-28-E6E7-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
| 17 | general cells |
JCRB1643 |
KYSE890 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 18 | general cells |
JCRB1877 |
NALM-32 |
human |
peripheral bood |
Biphenotypic features carrying myeloperoxidase mRNA and protein with complex Philadelphia (Ph) chromosome, t(9;22;10)(q34;q11;q22), cell line establish from acute leukemia patient. Derived from the same patient as NALM-27, NALM-28, NALM-30, NALM-31. |
|
| 19 | general cells |
JCRB1885 |
HSC-64 |
human |
ascites |
Human gastric carcinoma (poor differentiated adenocarcinoma) cell line establised in vitro from ascites. |
|
| 20 | general cells |
JCRB1892 |
OCUT-3 |
human |
lymph node |
human anaplastic thyroid cancer cell line |
|
| 21 | general cells |
JCRB1929 |
Sui77 |
human |
liver metastasis |
Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from liver metastasis. |
|
| 22 | general cells |
JCRB4186 |
UMK-1 |
human |
bladder |
Bladder carcinoma cell line |
|
| 23 | general cells |
JCRB9111 |
BeWo |
human |
fetal placenta |
Human placenta derived cell line. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.